Autoimmunity in autism
Abstract
Autism spectrum disorders is a heterogenous group of neurodevelopmental disorders, the etiology or etiologies of which remain unknown. Increasing evidence of autoimmune phenomena in individuals with autism could represent the presence of altered or inappropriate immune responses in this disorder, and this immune system dysfunction may represent novel targets for treatment. Furthermore, in recent studies, antibodies directed against the fetal brain have been detected in some mothers of children with autism; these antibodies have the ability to alter behavioral outcomes in the offspring of animal models. A better understanding of the involvement of the immune response in early brain development, with respect to autism, may have important therapeutic implications.
References
-
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR: 4th edition American Psychiatric Association Publishing Inc, Washington DC, USA: (2000).
-
- Brachlow AE, Ness KK, McPheeters ML, Gurney JG: Comparison of indicators for a primary care medical home between children with autism or asthma and other special health care needs: National Survey of Children’s Health. Arch Pediatr Adolesc Med 161(4):399–405. - PubMed
-
- Lord C, Leventhal BL, Cook EH Jr: Quantifying the phenotype in autism spectrum disorders. Am J Med Genet (2001) 105(1):36–38. - PubMed
-
- Rogers SJ: Developmental regression in autism spectrum disorders. Ment Retard Dev Disabil Res Rev (2004) 10(2):139–143. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources